Entrada Therapeutics Inc.
TRDA | NASDAQ
$6.79
+$0.15 (+2.26%)
Sep 22, 2026, 1:19 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.69M | 5.74M | 25.42M | 61.52M | 79.48M | 172.22M | 210.78M | 215.23M | 239.4M | 162.87M | 129.01M | 87.17M | 43.43M | 25.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 40.05M | 40.05M | 39.25M | 38.36M | n/a | n/a | n/a | n/a | 22.19M | 48.49M | 71.59M | 71.59M | 49.4M | 23.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -35.37M | -34.31M | -13.83M | 23.16M | 79.48M | 172.22M | 210.78M | 215.23M | 217.21M | 114.38M | 57.42M | 15.57M | -5.97M | 2.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -176.53M | -178.41M | -157.9M | -121.56M | -96.16M | 4.11M | 47.01M | 57.78M | 93.45M | 23.73M | -3.16M | -33.65M | -73.59M | -80.88M | -97.25M | -90.13M | -78.56M | -64.89M | -51.13M | -41.32M | -33.93M | -29.54M |
Interest Income | 11.57M | 13.26M | 15.07M | 17.06M | 19.26M | 19.7M | 19.47M | 18.64M | 16.92M | 16.78M | 15.22M | 10.93M | 7.67M | 3.86M | 1.68M | 1.7M | 896K | 502K | 35K | 22K | 22K | 13K |
Pretax Income | -164.96M | -165.16M | -142.83M | -104.49M | -76.91M | 23.81M | 66.49M | 76.42M | 145.17M | 75.3M | 46.85M | 13.03M | -64.97M | -76.07M | -94.62M | -88.43M | -77.73M | -64.45M | -51.16M | -41.38M | -33.94M | -29.47M |
Net Income | -165.78M | -166.12M | -143.75M | -103.46M | -73.35M | 24.78M | 65.63M | 54.95M | 104.44M | 23.49M | -6.69M | -21.77M | -82.37M | -79.62M | -94.62M | -88.43M | -77.73M | -64.45M | -51.16M | -41.38M | -33.94M | -29.47M |
Selling & General & Admin | 40.47M | 40.9M | 41.05M | 41.36M | 41.03M | 39.34M | 38.47M | 37.26M | 34.82M | 33.75M | 32.29M | 33.53M | 32.98M | 32.14M | 30.64M | 26.84M | 23.72M | 19.46M | 15.2M | 11.1M | 8.52M | 6.59M |
Research & Development | 140.74M | 143.25M | 142.27M | 141.72M | 134.61M | 128.77M | 125.31M | 120.19M | 111.13M | 105.39M | 99.88M | 87.28M | 84.05M | 73.99M | 66.61M | 63.29M | 54.84M | 45.42M | 35.93M | 30.22M | 25.41M | 22.95M |
Other Expenses | -40.05M | -40.05M | -39.25M | -38.36M | n/a | n/a | n/a | n/a | -22.19M | -48.49M | -71.59M | -71.59M | -49.4M | -23.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 141.16M | 144.1M | 144.07M | 144.72M | 175.64M | 168.11M | 163.77M | 157.45M | 123.75M | 90.65M | 60.58M | 49.22M | 67.62M | 83.04M | 97.25M | 90.13M | 78.56M | 64.89M | 51.13M | 41.32M | 33.93M | 29.54M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 66K | 66K | 66K | 86K | 37K | 37K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 181.21M | 184.15M | 183.32M | 183.08M | 175.64M | 168.11M | 163.77M | 157.45M | 145.94M | 139.14M | 132.18M | 120.81M | 117.02M | 106.14M | 97.25M | 90.13M | 78.56M | 64.89M | 51.13M | 41.32M | 33.93M | 29.54M |
Income Tax Expense | 819K | 962K | 924K | -1.04M | -3.55M | -972K | 859K | 21.47M | 40.73M | 51.82M | 53.54M | 34.8M | 17.4M | 3.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 42.22M | 41.84M | 41.37M | 41.46M | 41.34M | 41.07M | 40.84M | 40.63M | 34.18M | 33.5M | 33.37M | 33.28M | 33.16M | 32.37M | 31.35M | 31.3M | 31.28M | 31.25M | 20.78M | 28.31M | 20.48M | 20.48M |
Shares Outstanding (Diluted) | 42.22M | 41.84M | 41.37M | 41.46M | 41.34M | 41.07M | 43.05M | 40.63M | 35.51M | 34.79M | 33.37M | 34.78M | 33.16M | 32.37M | 31.35M | 31.3M | 31.28M | 31.25M | 20.78M | 28.31M | 20.48M | 20.48M |
EPS (Basic) | -3.97 | -4 | -3.47 | -2.49 | -1.78 | 0.87 | 1.99 | 1.67 | 3.09 | 0.70 | -0.21 | -0.63 | -2.45 | -2.39 | -2.84 | -3.02 | -2.78 | -2.54 | -2.29 | -1.82 | -1.65 | -6.35 |
EPS (Diluted) | -3.97 | -4 | -3.47 | -2.49 | -1.78 | 0.81 | 1.91 | 1.59 | 2.96 | 0.63 | -0.26 | -0.68 | -2.45 | -2.39 | -2.84 | -3.02 | -2.78 | -2.54 | -2.29 | -1.82 | -1.65 | -6.35 |
EBITDA | -164.87M | -164.87M | -142.4M | -100.29M | -73M | 27.59M | 70.26M | 79.94M | 148.59M | 78.54M | 49.69M | 15.66M | -62.66M | -74.02M | -92.72M | -86.7M | -76.14M | -63.08M | -49.99M | -40.46M | -33.28M | -29.08M |
EBIT | -164.96M | -165.16M | -142.83M | -104.49M | -76.91M | 23.81M | 66.49M | 76.42M | 145.17M | 75.3M | 46.85M | 13.03M | -64.97M | -76.07M | -94.62M | -88.43M | -77.66M | -64.38M | -51.11M | -41.31M | -33.92M | -29.54M |
Depreciation & Amortization | 91K | 284K | 425K | 4.2M | 3.91M | 3.79M | 3.77M | 3.52M | 3.41M | 3.23M | 2.84M | 2.63M | 2.31M | 2.05M | 1.89M | 1.73M | 1.52M | 1.31M | 1.12M | 851K | 639K | 456K |
Add to Watchlist
Select watchlists to add or remove TRDA